Company Search:
Advanced Search
Sponsored Links
Ceapro Inc Company Snapshot
Ceapro Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Ceapro Inc with three other miscellaneous service companies in North America: Epizyme Inc of the United States (2017 sales of $10.00 million of which 100% was Bio-Pharmaceutical), Exicure Inc of the United States ($9.72 million ), and Anaptysbio Inc which is also based in the United States ($10.00 million of which 100% was Pharmaceutical).

Sales Analysis. During the year ended December of 2017, sales at Ceapro Inc were C$12.93 million (US$9.83 million). This is a decrease of 5.5% versus 2016, when the company's sales were C$13.67 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Ceapro Inc
  Stock Performance Chart for Ceapro Inc
  Stock Data: Recent Stock Performance:
  Current Price (11/16/2018): .46
(Figures in Canadian Dollars)
1 Week -9.8%   13 Weeks 15.0%  
4 Weeks -6.1%   52 Weeks -17.9%  
Ceapro Inc Key Data:
  Ticker: CZO Country: Canada
  Exchanges: VEN Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 12,925,825
(Year Ending Jan 2018).
Employees: N/A
  Currency: Canadian Dollars Market Cap: 35,440,704
  Fiscal Yr Ends: December Shares Outstanding: 77,045,008
  Share Type: Closely Held Shares: 5,328,681
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.